Skip to main content

Table 1 Characteristics of included literature

From: Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review

Characteristics of included documents (n = 72)

n

%

1. Literature type

 Original research

23

32

 Review

17

24

 Perspective article

11

15

 Project report

7

10

 Systematic review

4

6

 Workshop report

3

4

 Regulatory document

2

3

 HTA report

2

3

 Other

3

4

2. Main decision-making context described

 BRA/MA

25

35

 HTA/reimbursement

15

21

 BRA/MA + HTA/reimbursement

12

17

 IPDM

5

7

 ITD + BRA/MA

3

4

 IPDM + HTA/reimbursement + BRA/MA

3

4

 IPDM + BRA/MA

4

6

 ITD + BRA/MA + HTA/reimbursement

2

3

 BRA/MA + HTA/reimbursement + ITD + CPG

1

1

 HTA/reimbursement + IPDM

1

1

 HTA/reimbursement + CPG

1

1

3. Stakeholder perspective

 Academic

44

61

 Regulatory authority

8

11

 Industry/CRO

7

10

 HTA body

3

4

 Patient organization

3

4

 Other

7

10

  1. Number and percentage of included documents per literature type, main decision-making context described and stakeholder perspective (bold font). Each document was assigned to a stakeholder perspective: for primary research articles, (systematic) reviews and perspective articles, the affiliation cited of the first author was used to assign a stakeholder perspective. For regulatory documents, the regulatory authority perspective was assigned. HTA reports were assigned to the HTA body perspective. For project reports, since those are written from multiple stakeholder perspectives, they could not be assigned to a specific stakeholder perspective. HTA Health Technology Assessment, BRA benefit-risk assessment, MA marketing authorization, IPDM industry processes and decision-making, CPG clinical practice guideline development, ITD individual treatment decision-making, CRO contract research organization